Sanofi Cash on Hand 2010-2024 | SNY | MacroTrends

Sanofi Cash on Hand 2010-2024 | SNY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sanofi cash on hand for the quarter ending June 30, 2024 was $7.318B, a 16.04% decline year-over-year.

Sanofi cash on hand for 2023 was $9.427B, a 29.75% decline from 2022.
Sanofi cash on hand for 2022 was $13.419B, a 12.32% increase from 2021.
Sanofi cash on hand for 2021 was $11.947B, a 24.84% decline from 2020.

Sanofi Cash on Hand 2010-2024 | SNY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sanofi cash on hand for 2023 was $9.427B, a 29.75% decline from 2022.
Sanofi cash on hand for 2022 was $13.419B, a 12.32% increase from 2021.
Sanofi cash on hand for 2021 was $11.947B, a 24.84% decline from 2020.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$495.1B
Johnson & Johnson (JNJ)	$450.1B
Novo Nordisk (NVO)	$424.5B
Merck (MRK)	$270B
AbbVie (ABBV)	$264.1B
AstraZeneca (AZN)	$218.5B
Novartis AG (NVS)	$218.4B
Pfizer (PFE)	$201.2B
Innoviva (INVA)	$953M